spot_img
HomeBusinessAesthetic Medical Worldwide Broadcasts Receipt of Nasdaq Notification Letter Concerning Minimal Bid...

Aesthetic Medical Worldwide Broadcasts Receipt of Nasdaq Notification Letter Concerning Minimal Bid Worth Deficiency Receive US

SHENZHEN, China, Sept. 08, 2023 (GLOBE NEWSWIRE) — Aesthetic Medical Worldwide Holdings Group Restricted (Nasdaq: AIH) (the “Firm” or “AIH”), a number one supplier of aesthetic medical companies in China, introduced that it has obtained a notification letter (the “Notification Letter”) from the Nasdaq Inventory Market LLC (the “Nasdaq”) dated September 6, 2023, notifying the Firm that it’s not in compliance with the minimal bid value requirement as set forth underneath Nasdaq Itemizing Rule 5550(a)(2) for continued itemizing on the Nasdaq. This press launch is issued pursuant to Nasdaq Itemizing Rule 5810(b), which requires immediate disclosure upon the receipt of a deficiency notification.

Nasdaq Itemizing Rule 5550(a)(2) requires listed securities to keep up a minimal bid value of US$1.00 per share, and Itemizing Rule 5810(c)(3)(A) offers {that a} failure to fulfill the minimal bid value requirement exists if the deficiency continues for a interval of 30 consecutive enterprise days. Primarily based on the closing bid value of the Firm’s atypical shares for the 31 consecutive enterprise days from July 24, 2023 to September 5, 2023, the Firm now not meets the minimal bid value requirement.

In accordance with the Nasdaq Itemizing Rule 5810(c)(3)(A), the Firm has been supplied 180 calendar days, or till March 4, 2024, to regain compliance with Nasdaq Itemizing Rule 5550(a)(2). To regain compliance, the Firm’s atypical shares will need to have a closing bid value of not less than US$1.00 for no less than 10 consecutive enterprise days. Within the occasion that the Firm doesn’t regain compliance by March 4, 2024, the Firm could also be eligible for extra time to regain compliance or could face delisting.

The receipt of the Notification Letter has no quick impact on the Firm’s enterprise operations or the itemizing of the Firm’s atypical shares, which is able to proceed to commerce uninterrupted on the Nasdaq underneath the ticker “AIH”. To handle this concern, the Firm intends to repeatedly monitor its closing bid value and is within the means of contemplating numerous measures to enhance its monetary place and outcomes of operations, which the Firm expects to countervail the short-term opposed results on its buying and selling value and remedy the deficiency in due time.

About Aesthetic Medical Worldwide Holdings Group Restricted

AIH, often known as “Peng’ai” in China, is a number one supplier of aesthetic medical companies in China. AIH operates by therapy facilities which are unfold throughout main cities in mainland China, with a significant deal with the Guangdong-Hong Kong-Macau Higher Bay space and the Yangtze River Delta space. Leveraging over 20 years of medical expertise, AIH offers one-stop aesthetic service choices, together with surgical aesthetic remedies, non-surgical aesthetic remedies, normal medical companies, and different aesthetic companies. For extra info concerning the Firm, please go to /.

Cautionary Statements

This press launch accommodates “forward-looking statements.” These statements are made underneath the “secure harbor” provisions of the U.S. Non-public Securities Litigation Reform Act of 1995. These forward-looking statements could be recognized by terminology reminiscent of “will”, “expects”, “anticipates”, “goals”, “future”, “intends”, “plans”, “believes”, “estimates”, “prone to” and related statements. Statements that aren’t historic information, together with statements in regards to the Firm’s beliefs, plans and expectations, are forward-looking statements. Ahead-looking statements contain inherent dangers and uncertainties. These dangers and uncertainties and others that relate to the Firm’s enterprise and monetary situation are detailed sometimes within the Firm’s SEC filings, and will trigger the precise outcomes to vary materially from these contained in any forward-looking assertion. These forward-looking statements are made solely as of the date indicated, and the Firm undertakes no obligation to replace or revise the knowledge contained in any forward-looking statements, besides as required underneath relevant legislation.

Investor Relations Contacts

For investor and media inquiries, please contact:
Aesthetic Medical Worldwide Holdings Group Restricted
E mail: [email protected]
Web site: 

#Aesthetic #Medical #Worldwide #Broadcasts #Receipt #Nasdaq #Notification #Letter #Minimal #Bid #Worth #Deficiency

RELATED ARTICLES
Continue to the category

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisment -spot_img

Most Popular

Recent Comments